Feinstein Institutes’ Haichao Wang named president-elect of Shock Society
2024年6月19日 - 12:58AM
ビジネスワイヤ(英語)
Dr. Wang officially took the role of
president-elect after the 47th Annual Conference on Shock in Palm
Beach Gardens, Florida
Sepsis, a silent killer that can cause shock and multiple organ
failure, makes up almost a quarter of deaths worldwide. For his
dedication to sepsis research and finding new therapies, Haichao
Wang, PhD, professor in the Institute of Molecular Medicine at The
Feinstein Institutes for Medical Research, has been named
president-elect of the Shock Society.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240618905351/en/
Dr. Haichao Wang, professor in the
Institute of Molecular Medicine at the Feinstein Institutes for
Medical Research, has recently been named president-elect of the
Shock Society.
The Shock Society was founded in 1978 by a group of dedicated
clinicians and researchers whose mission is to improve the care of
victims of trauma, shock and sepsis by promoting clinically
relevant research, providing a multidisciplinary forum to integrate
and disseminate new knowledge, and promoting the education and
mentoring of the next generation of investigators in the field.
Sepsis is a complex clinical syndrome, but previous failures of
many sepsis trials targeting early inflammatory mediators have
taught us to be more resilient and innovative. Dr. Wang has
dedicated his career to studying the body's natural immune system,
with a specific focus on identifying late-acting mediators of
dysregulated immune responses to severe infections with relatively
wider therapeutic windows. His research involves investigating how
various natural immune system regulators function in septic
patients, employing both genetic and drug-based methods to gain
insights into these processes. He has worked on creating new
treatments to manage dysregulated inflammation – the leading cause
of sepsis.
“It is an honor and privilege to be chosen as the
president-elect of the Shock Society and to help lead this
dedicated group of professionals in advancing sepsis research,”
said Dr. Wang. “Instead of being deterred by previous failures of
sepsis trials, we should embrace them as opportunities for learning
and transformative power for innovation. In this role, I aim to
promote both preclinical investigations of complex sepsis
pathophysiology and the clinical development of innovative
therapies for this devastating disease.”
Dr. Wang received his PhD in microbiology from Louisiana State
University in 1992 and subsequently finished a three-year
postdoctoral fellowship in cell biology at the University of North
Carolina-Chapel Hill. Since joining the Feinstein Institutes in
1995, Dr. Wang has published more than 200 research and review
articles in the field of inflammation and sepsis with a total
citation of more than 60,000 times.
"Dr. Wang's pioneering research in identifying molecular targets
for sepsis and shock has paved the way for discovering new
treatment mechanisms," said Kevin J. Tracey, MD, president and CEO
of the Feinstein Institutes and Karches Family Distinguished Chair
in Medical Research. "His new role as president-elect of the Shock
Society is a well-deserved recognition of his dedication and
groundbreaking contributions."
Last year, Dr. Wang published in Science Advances the findings
of a novel protein that could be a potential therapeutic target for
lethal sepsis and other infectious diseases, including
COVID-19.
About the Feinstein Institutes
The Feinstein Institutes for Medical Research is the home of the
research institutes of Northwell Health, the largest health care
provider and private employer in New York State. Encompassing 50
research labs, 3,000 clinical research studies and 5,000
researchers and staff, the Feinstein Institutes raises the standard
of medical innovation through its five institutes of behavioral
science, bioelectronic medicine, cancer, health system science, and
molecular medicine. We make breakthroughs in genetics, oncology,
brain research, mental health, autoimmunity, and are the global
scientific leader in bioelectronic medicine – a new field of
science that has the potential to revolutionize medicine. For more
information about how we produce knowledge to cure disease, visit
http://feinstein.northwell.edu and follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240618905351/en/
Julianne Mosher Allen 516-880-4824
jmosherallen@northwell.edu